The role of lipopeptidophosphoglycan in the immune response to entamoeba histolytica

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Wong Baeza, Isabel ^a,b   Alcántara Hernández, Marcela ^a,b   Mancilla Herrera, Ismael ^a,b   Ramírez Saldívar, Itzmel ^a,b   Arriaga Pizano, Lourdes ^a   Ferat Osorio, Eduardo ^a   López Macías, Constantino ^a   Isibasi, Armando ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD1D ANTIGEN; CHEMOKINE RECEPTOR CCR1; GAMMA INTERFERON; GLYCAN PHOSPHATE LIPOPROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPHOSPHOGLYCAN; LIPOPOLYSACCHARIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; POLYSACCHARIDE; PORIN; PROFILIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; PARASITE ANTIGEN; PEPTIDOGLYCAN; PHOSPHOLIPID;

ADAPTIVE IMMUNITY; AMEBIASIS; ANTIBODY PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE COURSE; ENDOSOME; ENTAMOEBA HISTOLYTICA; HUMAN; IMMUNOGENICITY; INNATE IMMUNITY; LIVER AMEBIASIS; MACROPHAGE; MOLECULE; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; REVIEW; SIGNAL TRANSDUCTION; TROPHOZOITE; ANIMAL; BIOLOGICAL MODEL; IMMUNOLOGY;

ANIMALIA; ENTAMOEBA HISTOLYTICA;

ANIMALS; ANTIGENS, PROTOZOAN; ENTAMOEBA HISTOLYTICA; ENTAMOEBIASIS; HUMANS; MODELS, IMMUNOLOGICAL; PEPTIDOGLYCAN; PHOSPHOLIPIDS;

EID: 77951922184     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/254521     Document Type: Review

References (133)

1. J. Araujo, M. E. García, O. Diaz-Suárez, and H. Urdaneta, "Amebiasis: importance of the diagnosis and treatment. Minireview," Investigacion Clínica, vol. 49, no. 2, pp. 265-271, 2008.
2. G. A. Nari, E. R. Ceballos, G. Carrera Ladrón, et al., "Amebic liver abscess. Three years experience," Revista Espanola de Enfermedades Digestivas, vol. 100, no. 5, pp. 268-272, 2008. (Pubitemid 351966964)
3. R. Graillet, M. Sanchez Aguilar, A. O. Morán-Mendoza, J. F. Hernandez-Sierra, A. Gordillo-Moscoso, and J. H. Tapia-Pérez, "Analysis of factors associated to failure of medical treatment of amoebic liver abscess," Cirugía Espanola, vol. 84, no. 2, pp. 83-86, 2008.
4. R. Khan, S. Hamid, S. Abid, et al., "Predictive factors for early aspiration in liver abscess," World Journal of Gastroenterology, vol. 14, no. 13, pp. 2089-2093, 2008. (Pubitemid 351795832)
5. B. S. Pritt and G. C. Clark, "Amebiasis," Mayo Clinic Proceedings, vol. 83, no. 10, pp. 1154-1160, 2008.
6. S. L. Stanley Jr., "Amoebiasis," The Lancet, vol. 361, no. 9362, pp. 1025-1034, 2003. (Pubitemid 36351374)
7. J. Araujo, M. García, O. Díaz-Suárez, et al., "Amebiasis: relevance of its diagnosis and treatment," Investigacion Clínica, vol. 49, no. 2, pp. 265-271, 2008.
8. D. S. Blanc, "Determination of taxonomic status of pathogenic and nonpathogenic Entamoeba histolytica zymodemes using isoenzyme analysis," Journal of Protozoology, vol. 39, no. 4, pp. 471-479, 1992.
9. D. A. Bruckner, "Amebiasis," Clinical Microbiology Reviews, vol. 5, no. 4, pp. 356-369, 1992.
10. Mexican Secretary of Health, "Epidemiological Survey, week 12. Cases per federal entity of infectious and parasitic diseases of the digestive apparatus, until week 12, 2009," Mexico, May 2009, http://www.dgepi.salud. gob.mx/boletin/2009/sem13/pdf/cua4.3.pdf ́́
11. L. Avalos-Chávez, "Amebiasis," in Pediatry, L. Avalos-́́ Chávez, X. Avalos-Huízar, and L. Avalos-Huízar, Eds., Jalisco, México, 2007.
12. L. F. Cervantes, F. González-Montesinos, L. Landa, and B. Sepulveda, "Comparative study of drugs used in the treatment of acute amebic hepatic abscess," Archivos de Investigación Ḿedica, vol. 1, supplement 6, 216 pages, 1970.
13. G. Gutierrez, J. C. Margain, R. Castaneda, O. Enriquez, M. Aubanel, and B. Sepulveda, "National serologic survey. I. Study of antibodies against E. histolytica in a semirural locality on the Gulf of Mexico Coast," Archivos de Investigacío n M ́edica, vol. 5, supplement 2, pp. 475-480, 1974.
14. G. Gutiérrez, A. Ludlow, G. Espinoza, et al., "Antibodies against Entamoeba histolytica in the Mexican Republic. 1974," Salud Publica de Mexico, vol. 34, no. 2, pp. 242-254, 1992.
15. L. Landa, M. Aubanel, E. Segovia, and B. Sepúlveda, "Seroepidemiology of amebiasis in adults," Archivos de Investigación Ḿedica, vol. 2, supplement 80, pp. 377-380, 1972.
16. A. Perches, R. Kretschmer, E. Lee, and B. Sepulveda, "Determination of immunoglobulins in serum from patients with invasive amebiasis," Archivos de Investigación Ḿedica, vol. 1, supplement 100, 1970.
17. G. M. Ruiz-Palacios, G. Castanon, R. Bojalil, et al., "Low risk of invasive amebiasis in cyst carriers. A longitudinal molecular seroepidemiological study," Archives of Medical Research, vol. 23, no. 2, pp. 289-291, 1992. (Pubitemid 23062729)
18. +(-)dependent alcohol dehydrogenase gene," Biochimica et Biophysica Acta, vol. 1306, no. 1, pp. 23-26, 1996. (Pubitemid 26120711)
19. M. A. Rodríguez, M. E. Hidalgo, T. Sanchez, and E. Orozco, "Cloning and characterization of the Entamoeba histolytica pyruvate: ferredoxin oxidoreductase gene," Molecular and Biochemical Parasitology, vol. 78, no. 1-2, pp. 273-277, 1996. (Pubitemid 26201625)
20. C. López-Camarillo, M. de la Luz García-Hernández, L. A. Marchat, et al., "Entamoeba histolytica EhDEAD1 is a conserved DEAD-box RNA helicase with ATPase and ATP-dependent RNA unwinding activities," Gene, vol. 414, no. 1-2, pp. 19-31, 2008.
21. M. G. Meléndez-Hernández, M. L. L. Barrios, E. Orozco, and J. P. Luna-Arias, "The Vacuolar ATPase from Entamoeba histolytica: molecular cloning of the gene encoding for the B subunit and subcellular localization of the protein," BMC Microbiology, vol. 8, article 235, 2008.
22. E. Orozco, C. López, C. Gomez, D. G. Perez, L. Marchat, C. Bañuelos, and D. M. Delgadillo, "Multidrug resistance in the protozoan parasite Entamoeba histolytica," Parasitolog y International, vol. 51, no. 4, pp. 353-359, 2002. (Pubitemid 35287507)
23. R. Arroyo and E. Orozoco, "Localization and identification of an Entamoeba histolytica adhesin," Molecular and Biochemical Parasitology, vol. 23, no. 2, pp. 151-158, 1987. (Pubitemid 17041365)
24. G. García-Rivera, M. A. Rodríguez, R. Ocádiz, et al., "Enta-moeba histolytica: a novel cysteine protease and an adhesin form the 112 kDa surface protein," Molecular Microbiology, vol. 33, no. 3, pp. 556-568, 1999. (Pubitemid 29387180)
25. C. Martínez-López, E. Orozco, T. Sánchez, R. M. García-Pérez, F. Hernandez-Hernandez, and M. A. Rodríguez, "The EhADH112 recombinant polypeptide inhibits cell destruction and liver abscess formation by Entamoeba histolytica trophozoites," Cellular Microbiology, vol. 6, no. 4, pp. 367-376, 2004. (Pubitemid 38379819)
26. B. Sepulveda, M. Tanimoto-tweki, P. Calderon, and R. de la Hoz, "Neutralization of the virulence of E. histolytica cultures with immune serums," Archivos de Investigación Ḿedica, vol. 5, supplement 2, pp. 447-450, 1974.
27. B. Sepulveda, M. Tanimoto-tweki, P. Calderon, and R. de la Hoz, "Induction of antiamebic passive immunity in hamsters by injecting immune serum," Archivos de Investigació n M ́edica, vol. 5, supplement 2, pp. 451-456, 1974.
28. M. Lopez-Osuna, J. Arellano, and R. R. Kretschmer, "The destruction of virulent Entamoeba histolytica by activated human eosinophils," Parasite Immunology, vol. 14, no. 6, pp. 579-586, 1992.
29. J. R. Velázquez, P. Llaguno, J. Fernández-Diéz, et al., "Antigen induced eosinophilia protects gerbils (Meriones unguiculatus) against experimental amebic abscess of the liver," Archives of Medical Research, vol. 26, pp. S93-S98, 1995. (Pubitemid 26044936)
30. M. Shibayama, V. Rivera-Aguilar, E. Barbosa-Cabrera, et al., "Innate immunity prevents tissue invasion by Entamoeba histolytica," Canadian Journal of Microbiology, vol. 54, no. 12, pp. 1032-1042, 2008.
31. R. A. Salata, A. Martinez-Palomo, and H. W. Murray, "Patients treated for amebic liver abscess develop cellmediated immune responses effective in vitro against Enta-moeba histolytica," Journal of Immunology, vol. 136, no. 7, pp. 2633-2639, 1986. (Pubitemid 16136850)
32. R. Kretschmer, M. L. Collado, and M. G. Pacheco, "Inhibition of human monocyte locomotion by products of axenically grown E. histolytica," Parasite Immunology, vol. 7, no. 5, pp. 527-543, 1985. (Pubitemid 16256169)
33. R. R. Kretschmer, G. Rico, and J. A. Giménez, "A novel anti-inflammatory oligopeptide produced by Entamoeba histolytica," Molecular and Biochemical Parasitology, vol. 112, no. 2, pp. 201-209, 2001. (Pubitemid 32167097)
34. D. Utrera-Barillas, J. R. Velazquez, A. Enciso, et al., "An anti-inflammatory oligopeptide produced by Entamoeba his-tolytica down-regulates the expression of pro-inflammatory chemokines," Parasite Immunology, vol. 25, no. 10, pp. 475-482, 2003. (Pubitemid 38333809)
35. + cells exposed to the monocyte locomotion inhibitory factor produced by Entamoeba histolytica," Para-sitology Research, vol. 98, no. 5, pp. 493-495, 2006.
36. J. A. Gimenez-Scherer, G. Cardenas, M. Lopez-Osuna, et al., "Immunization with a tetramer derivative of an anti-inflammatory pentapeptide produced by Entamoeba histolyt-ica protects gerbils (Meriones unguiculatus) against experimental amoebic abscess of the liver," Parasite Immunology, vol. 26, no. 8-9, pp. 343-349, 2004. (Pubitemid 40238616)
37. C. Galanos, O. Lüderitz, and O. Westphal, "A new method for the extraction of R lipopolysaccharides," European Journal of Biochemistry, vol. 9, no. 2, pp. 245-249, 1969.
38. C. Galanos, E. T. Rietschel, O. Lüderitz, O. Westphal, Y. B. Kim, and D. W. Watson, "Biological activities of lipid A complexed with bovine-serum albumin.," European Journal of Biochemistry, vol. 31, no. 2, pp. 230-233, 1972.
39. C. Galanos, V. Lehmann, and O. Luderitz, "Endotoxic properties of chemically synthesized lipid A structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A ," European Journal of Biochemistry, vol. 140, no. 2, pp. 221-227, 1984. (Pubitemid 14139826)
40. M. K. Hoffmann, C. Galanos, S. Koenig, and H. F. Oettgen, "B-cell activation by lipopolysaccharide. Distinct pathways for induction of mitosis and antibody production," Journal of Experimental Medicine, vol. 146, no. 6, pp. 1640-1647, 1977. (Pubitemid 8245447)
41. O. Luderitz, C. Galanos, and V. Lehmann, "LipidA: chemical structure and biological activity," Journal of Infectious Diseases, vol. 128, supplement, pp. S17-S29, 1973.
42. O. Lüderitz, C. Galanos, V. Lehmann, H. Mayer, E. T. Rietschel, and J. Weckesser, "Chemical structure and biological activities of lipid A's from various bacterial families," Naturwissenschaften, vol. 65, no. 11, pp. 578-585, 1978.
43. E. T. Rietschel, Y. B. Kim, D. W. Watson, C. Galanos, O. Luderitz, and O. Westphal, "Pyrogenicity and immunogenic-ity of lipid A complexed with bovine serum albumin or human serum albumin," Infection and Immunity, vol. 8, no. 2, pp. 173-177, 1973.
44. K. I. Tanamoto, U. Zahringer, and G. R. McKenzie, "Biological actitivies of synthetic LipidA analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate," Infection and Immunity, vol. 44, no. 2, pp. 421-426, 1984. (Pubitemid 14139008)
45. A. Isibasi, C. M. Santa, A. Ramirez, and J. Kumate, "Immuno- chemistry of a lipopeptidophosphoglycan extracted from trophozoites of Entamoeba histolytica strain HK-9 cultivated in axenic media, using the phenol-water method," Archivos de Investigacion Ḿedica, vol. 13, supplement 3, pp. 51-55, 1982. (Pubitemid 13200943)
46. A. Isibasi, C. M. Santa, M. Soto, A. Ramirez, and J. Kumate, "Localization of a lipopeptidophosphoglycan extracted by phenol-water from trophozoites of the HK-9 strain of Entamoeba histolytica" Archivos de Investigacion Ḿedica, vol. 13, Supplement 3, pp. 57-62, 1982. (Pubitemid 13200944)
47. G. Acosta, C. Barranco, A. Isibasi, R. Campos, and J. Kumate, "Excretion of anti-ameba specific antibodies of class IgA in bile from rats immunized with trophozoites of Entamoeba histolytica cultivated in axenic media," Archivos de Investigacion Ḿedica, vol. 13, Supplement 3, pp. 255-259, 1982. (Pubitemid 13200969)
48. G. Acosta-Altamirano, E. Torres-Sánchez, E. Meraz, A. Isibasi-Araujo, and J. Kumate-Rodríguez, "Detection of class IgA antibodies directed against a lipopeptidophosphoglycan of E. histolytica in samples of human colostrum," Archivos de Investigaciósn Ḿedica, vol. 17, supplement 1, pp. 291-295, 1986.
49. R. Campos Rodríguez, C. Barranco-Tovar, A. Isibasi-Araujo, and J. Kumate-Rodríguez, "Anti-amebic plasma cells in peripheral blood of patients with amebic liver abscess," Archivos de Investigacion Ḿedica, vol. 17, supplement 1, pp. 303-306, 1986.
50. C. Agundis, A. Isibasi, V. Oríz, et al., "Obtaining monoclonal antibodies against outer membrane glycoproteins of Entamoeba histolytica" Archivos de Investigacion Ḿedica, vol. 21, supplement 1,pp. 15-22, 1990.
51. A. Bhattacharya, R. Ghildyal, S. Bhattacharya, and L. S. Diamond, "Characterization of a monoclonal antibody that selectively recognizes a subset of Entamoeba histolytica isolates," Infection and Immunity, vol. 58, no. 10, pp. 3458-3461, 1990. (Pubitemid 20293464)
52. A. Marinets, T. Zhang, N. Guillen, et al., "Protection against invasive amebiasis by a single monoclonal antibody directed against a lipophosphoglycan antigen localized on the surface of Entamoeba histolytica" Journal of Experimental Medicine, vol. 186, no. 9, pp. 1557-1565, 1997. (Pubitemid 27479815)
53. Y. C. Yau, I. Crandall, and K. C. Kain, "Development of monoclonal antibodies which specifically recognize Entamoeba histolytica in preserved stool samples," Journal of Clinical Microbiology, vol. 39, no. 2, pp. 716-719, 2001. (Pubitemid 32150844)
54. S. I. Miller, R. K. Ernst, and M. W. Bader, "LPS, TLR4 and infectious disease diversity," Nature Reviews Microbiology, vol. 3, no. 1, pp. 36-46, 2005. (Pubitemid 40028467)
55. N. Burdin, L. Brossay, Y. Koezuka, et al., "Selective ability of mouse CD1 to present glycolipids: alpha-galactosylceramide specifically stimulates V alpha 14+ NK T lymphocytes," Journal of Immunology, vol. 161, no. 7, pp. 3271-3281, 1998.
56. M. Aubanel, M. Torre-Robles, and B. Sepúlveda, "Tropho-zoites of Entamoeba histolytica in material from patients with liver abscess," Archivos de Investigación Ḿedica, vol. 1, supplement, 30 pages, 1970.
57. C. G. Clark, U. C. M. Alsmark, M. Tazreiter, et al., "Structure and content of the Entamoeba histolytica genome," Advances in Parasitology, vol. 65, no. 2, pp. 51-190, 2007. (Pubitemid 350183945)
58. H. Lotter, N. González-Roldán, B. Lindner, et al., "Natural killer T cells activated by a lipopeptidophosphoglycan from Entamoeba histolytica are critically important to control amebic liver abscess," PLoS Pathogens, vol. 5, no. 5, Article ID e1000434, 2009.
59. B. Beutler and E. Th. Rietschel, "Innate immune sensing and its roots: the story of endotoxin," Nature Reviews Immunology, vol. 3, no. 2, pp. 169-176, 2003. (Pubitemid 37328694)
60. A. Coutinho, L. Forni, F. Melchers, and T. Watanabe, "Genetic defect in responsiveness to the B cell mitogen lipopolysaccharide," European Journal of Immunology, vol. 7, no. 5, pp. 325-328, 1977. (Pubitemid 8111306)
61. G. Heppner and D. W. Weiss, "High susceptibility of strain A mice to endotoxin and endotoxin-red blood cell mixtures," Journal of Bacteriology, vol. 90, no. 3, pp. 696-703, 1965.
62. A. Poltorak, X. He, I. Smirnova, et al., "Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene," Science, vol. 282, no. 5396, pp. 2085-2088, 1998. (Pubitemid 29001265)
63. C. Hashimoto, K. L. Hudson, and K. V. Anderson, "The Toll gene of drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein," Cell, vol. 52, no. 2, pp. 269-279, 1988.
64. B. Lemaitre, E. Nicolas, L. Michaut, J.-M. Reichhart, and J. A. Hoffmann, "The dorsoventral regulatory gene cassette spatzle/Toll/Cactus controls the potent antifungal response in Drosophila adults," Cell, vol. 86, no. 6, pp. 973-983, 1996. (Pubitemid 26336801)
65. F. L. Rock, G. Hardiman, J. C. Timans, R. A. Kastelein, and J. F. Bazan, "A family of human receptors structurally related to Drosophila Toll," Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 2, pp. 588-593, 1998. (Pubitemid 28083787)
66. R. Medzhitov, P. Preston-Hurlburt, and C. A. Janeway Jr., "A human homologue of the Drosophila toll protein signals activation of adaptive immunity," Nature, vol. 388, no. 6640, pp. 394-397, 1997. (Pubitemid 27334820)
67. K. J. Ishii, C. Coban, and S. Akira, "Manifold mechanisms of toll-like receptor-ligand recognition," Journal of Clinical Immunology, vol. 25, no. 6, pp. 511-521, 2005. (Pubitemid 43011743)
68. K. J. Ishii, S. Koyama, A. Nakagawa, C. Coban, and S. Akira, "Host innate immune receptors and beyond: making sense of microbial infections," Cell Host and Microbe, vol. 3, no. 6, pp. 352-363, 2008. (Pubitemid 351773099)
69. B. Pulendran and R. Ahmed, "Translating innate immunity into immunological memory: implications for vaccine development," Cell, vol. 124, no. 4, pp. 849-863, 2006. (Pubitemid 43261457)
70. C. A. Janeway Jr., "Approaching the asymptote? Evolution and revolution in immunology," Cold Spring Harbor Symposia on Quantitative Biology, vol. 54, part 1, pp. 1-13, 1989. (Pubitemid 20177564)
71. R. T. Gazzinelli and E. Y. Denkers, "Protozoan encounters with Toll-like receptor signalling pathways: implications for host parasitism," Nature Reviews Immunology, vol. 6, no. 12, pp. 895-906, 2006. (Pubitemid 44851732)
72. M. J. McConville and M. A. J. Ferguson, "The structure, biosynthesis and function of glycosylated phosphatidyli-nositols in the parasitic protozoa and higher eukaryotes," Biochemical Journal, vol. 294, part 2, pp. 305-324, 1993. (Pubitemid 23268825)
73. A. Guha-Niyogi, D. R. Sullivan, and S. J. Turco, "Glycocon-jugate structures of parasitic protozoa," Glycobiology, vol. 11, no. 4, pp. 45R-59R, 2001.
74. M. J. de Veer, J. M. Curtis, T. M. Baldwin, et al., "MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Toll-like receptor 2 signaling," European Journal of Immunology, vol. 33, no. 10, pp. 2822-2831, 2003. (Pubitemid 37337148)
75. I. Becker, N. Salaiza, M. Aguirre, et al., "Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2," Molecular and Biochemical Parasitology, vol. 130, no. 2, pp. 65-74, 2003. (Pubitemid 37289124)
76. G. Krishnegowda, A. M. Hajjar, J. Zhu, et al., "Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: cell signaling receptors, glycosylphosphatidylinositol (GPI) structural requirement, and regulation of GPI activity," Journal of Biological Chemistry, vol. 280, no. 9, pp. 8606-8616, 2005. (Pubitemid 40349765)
77. F. P. Mockenhaupt, J. P. Cramer, and L. Hamann, "Tolllike receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria," Journal of Communicable Diseases, vol. 38, no. 3, pp. 230-245, 2006.
78. D. C. Gowda, "TLR-mediated cell signaling by malaria GPIs," Trendsin Parasitology , vol. 23, no. 12, pp. 596-604, 2007. (Pubitemid 350161430)
79. C. Ropert, B. S. Franklin, and R. T. Gazzinelli, "Role of TLRs/MyD88 in host resistance and pathogenesis during protozoan infection: lessons from malaria," Seminars in Immunopathology, vol. 30, no. 1, pp. 41-51, 2008. (Pubitemid 351178623)
80. R. M. de Lederkremer, C. Lima, M. I. Ramirez, M. A. J. Ferguson, S. W. Homans, and J. Thomas-Oates, "Complete structure of the glycan of lipopeptidophosphoglycan from Trypanosoma cruzi epimastigotes," Journal of Biological Chemistry, vol. 266, no. 35, pp. 23670-23675, 1991.
81. M. A. S. Campos, I. C. Almeida, O. Takeuchi, et al., "Activation of toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite," Journal of Immunology, vol. 167, no. 1, pp. 416-423, 2001. (Pubitemid 32567807)
82. A. Bafica, H. C. Santiago, R. Goldszmid, C. Ropert, R. T. Gazzinelli, and A. Sher, "Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection," Journal of Immunology, vol. 177, no. 6, pp. 3515-3519, 2006. (Pubitemid 44359881)
83. A. Ouaissi, E. Guilvard, Y. Delneste, et al., "The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection," Journal of Immunology, vol. 168, no. 12, pp. 6366-6374, 2002. (Pubitemid 34620060)
84. F. Debierre-Grockiego, N. Molitor, R. T. Schwarz, and C. G. K. Lüder, "Toxoplasma gondii glycosylphosphatidylinos-itols up-regulate major histocompatibility complex (MHC) molecule expression on primary murine macrophages," Innate Immunity, vol. 15, no. 1, pp. 25-32, 2009.
85. C. Maldonado-Bernal, C. J. Kirschning, Y. Rosenstein, et al., "The innate immune response to Entamoeba histolytica lipopeptidophosphoglycan is mediated by toll-like receptors 2 and 4," Parasite Immunology, vol. 27, no. 4, pp. 127-137, 2005. (Pubitemid 40806802)
86. F. Debierre-Grockiego, M. A. Campos, N. Azzouz, et al., "Activation of TLR2 and TLR4 by glycosylphosphatidylinos-itols derived from Toxoplasma gondii," Journal of Immunology, vol. 179, no. 2, pp. 1129-1137, 2007.
87. D. van der Kleij, E. Latz, J. F. H. M. Brouwers, et al., "A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates toll-like receptor 2 and affects immune polarization," Journal of Biological Chemistry, vol. 277, no. 50, pp. 48122-48129, 2002. (Pubitemid 35470760)
88. A.-C. Oliveira, J. R. Peixoto, L. B. De Arrada, et al., "Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospho-lipids and higher resistance to infection with T. cruzi," Journal of Immunology, vol. 173, no. 9, pp. 5688-5696, 2004. (Pubitemid 39392157)
89. H. S. Goodridge, F. A. Marshall, K. J. Else, et al., " Immunomodulation via novel use of TLR4 by the filarial nematode phosphorylcholine-containing secreted product, ES-62," Journal of Immunology, vol. 174, no. 1, pp. 284-293, 2005. (Pubitemid 40007415)
90. P. G. Thomas, M. R. Carter, O. Atochina, et al., "Maturation of dendritic cell 2 phenotype by a helminth glycan uses a Toll-like receptor 4-dependent mechanism," Journal of Immunology, vol. 171, no. 11, pp. 5837-5841, 2003. (Pubitemid 37467200)
91. C. Coban, K. J. Ishii, T. Kawai, et al., "Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin," Journal of Experimental Medicine, vol. 201, no. 1, pp. 19-25, 2005. (Pubitemid 40130079)
92. L. K. M. Shoda, K. A. Kegerreis, C. E. Suarez, et al., "DNA from protozoan parasites Babesia bovis, Trypanosoma cruzi, and T. brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric oxide," Infection and Immunity, vol. 69, no. 4, pp. 2162-2171, 2001. (Pubitemid 32239682)
93. F. H. Abou Fakher, N. Rachinel, M. Klimczak, J. Louis, and N. Doyen, "TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions," Journal of immunology, vol. 182, no. 3, pp. 1386-1396, 2009.
94. C. P. A. Ivory, M. Prystajecky, C. Jobin, and K. Chadee, "Toll-like receptor 9-dependent macrophage activation by Entamoeba histolytica DNA," Infection and Immunity, vol. 76, no. 1, pp. 289-297, 2008.
95. F. Yarovinsky, D. Zhang, J. F. Andersen, et al., "Immunology: TLR11 activation of dendritic cells by a protozoan profilin-like protein," Science, vol. 308, no. 5728, pp. 1626-1629, 2005. (Pubitemid 40807512)
96. C. Maldonado, W. Trejo, A. Ramirez, et al., "Lipophospho- peptidoglycan of Entamoeba histolytica induces an antiin-flammatory innate immune response and downregulation of toll-like receptor 2 (TLR-2) gene expression in human monocytes," Archives of Medical Research, vol. 31, no. 4, supplement 1, pp. S71-S73, 2000.
97. H. Vivanco-Cid, C. Alpuche-Aranda, I. Wong-Baeza, et al., "Lipopopeptidephosphoglycan from Entamoeba histolytica activates human macrophages and dendritic cells and reaches their late endosomes," Parasite Immunology, vol. 29, no. 9, pp. 467-474, 2007. (Pubitemid 47313230)
98. W. A. Petri Jr. and R. L. Schnaar, "Purification and characterization of galactose- and N- acetylgalactosamine-specific adhesin lectin of Entamoeba histolytica," Methods in Enzymology, vol. 253, pp. 98-104, 1995.
99. J. L. Rosales-Encina, I. Meza, A. Lopez-De-Leon, P. Talamas-Rohana, and M. Rojkind, "Isolation of a 220-kilodalton protein with lectin properties from a virulent strain of Entamoeba histolytica," Journal of Infectious Diseases, vol. 156, no. 5, pp. 790-797, 1987. (Pubitemid 17157430)
100. S. L. Stanley Jr., H. Huizenga, and E. Li, "Isolation and partial characterization of a surface glycoconjugate of Entamoeba histolytica," Molecular and Biochemical Parasitology, vol. 50, no. 1, pp. 127-138, 1992.
101. D. R. Boettner, C. D. Huston, J. A. Sullivan, and W. A. Petri Jr., "Entamoeba histolytica and Entamoeba dispar utilize externalized phosphatidylserine for recognition and phagocytosis of erythrocytes," Infection and Immunity, vol. 73, no. 6, pp. 3422-3430, 2005. (Pubitemid 40745885)
102. E. E. Avila and J. Calderon, "Entamoeba histolytica tropho-zoites: a surface-associated cysteine protease," Experimental Parasitology, vol. 76, no. 3, pp. 232-241, 1993. (Pubitemid 23196026)
103. T. Jacobs, I. Bruchhaus, T. Dandekar, E. Tannich, and M. Leippe, "Isolation and molecular characterization of a surface-bound proteinase of Entamoeba histolytica," Molecular Microbiology, vol. 27, no. 2, pp. 269-276, 1998. (Pubitemid 28035252)
104. N. Perreault, F. E. Herring-Gillam, N. Desloges, I. Bélanger, L.-P. Pageot, and J.-F. Beaulieu, "Epithelial vs mesenchymal contribution to the extracellular matrix in the human intestine," Biochemical and Biophysical Research Communications, vol. 248, no. 1, pp. 121-126, 1998. (Pubitemid 28418198)
105. S. L. Reed, W. E. Keene, and J. H. McKerrow, "Thiol proteinase expression and pathogenicity of Entamoeba his-tolytica," Journal of Clinical Microbiology, vol. 27, no. 12, pp. 2772-2777, 1989. (Pubitemid 20001344)
106. H. Scholze and W. Schulte, "On the specificity of a cysteine proteinase from Entamoeba histolytica," Biomedica Biochim-ica Acta, vol. 47, no. 2, pp. 115-123, 1988.
107. H. Scholze and E. Tannich, "Cysteine endopeptidases of Entamoeba histolytica," Methods in Enzymology, vol. 244, pp. 512-523, 1994.
108. W. Schulte and H. Scholze, "Action of the major protease from Entamoeba histolytica on proteins of the extracellular matrix," Journal of Protozoology, vol. 36, no. 6, pp. 538-543, 1989.
109. M. Espinosa-Cantellano and A. Martínez-Palomo, "Patho-genesis of intestinal amebiasis: from molecules to disease," Clinical Microbiology Reviews, vol. 13, no. 2, pp. 318-331, 2000. (Pubitemid 30205429)
110. A. Martinez-Palomo and M. Espinosa-Cantellano, "Amoebi-asis: new understanding and new goals," Parasitology Today, vol. 14, no. 1, pp. 1-3, 1998.
111. M. Okada and T. Nozaki, "New insights into molecular mechanisms of phagocytosis in Entamoeba histolytica by proteomic analysis," Archives of Medical Research, vol. 37, no. 2, pp. 244-252, 2006. (Pubitemid 43003626)
112. A. E. Pinilla, M. C. López, and D. F. Viasus, "History of the Entamoeba histolytica protozoan," Revista Ḿedica de Chile, vol. 136, no. 1, pp. 118-124, 2008.
113. K. Prathap and R. Gilman, "The histopathology of acute intestinal amebiasis. A rectal biopsy study.," American Journal of Pathology, vol. 60, no. 2, pp. 229-246, 1970.
114. M. E. Quintanar-Quintanar, A. Jarillo-Luna, V. Rivera-Aguilar, et al., "Immunosuppressive treatment inhibits the development of amebic liver abscesses in hamsters," Medical Science Monitor, vol. 10, no. 9, pp. BR317-BR324, 2004. (Pubitemid 39278552)
115. V. Tsutsumi, R. Mena-Lopez, F. Anaya-Velazquez, and A. Martinez-Palomo, "Cellular bases of experimental amebic liver abscess formation," American Journal of Pathology, vol. 117, no. 1, pp. 81-91, 1984. (Pubitemid 15200369)
116. M. De Lourdes Canales-Trevino, V. Tsutsumi, and A. Martinez-Palomo, "Role of macrophages and T-lymphocytes: resistance of guinea pigs to amebic liver infection," Archivos de Investigación Ḿedica, vol. 21, supplement 1, pp. 81-84, 1990.
117. V. Tsutsumi and M. Shibayama, "Experimental amebiasis: a selected review of some in vivo models," Archives of Medical Research, vol. 37, no. 2, pp. 210-220, 2006. (Pubitemid 43003622)
118. S. J. Kammanadiminti, B. J. Mann, L. Dutil, and K. Chadee, "Regulation of Toll-like receptor-2 expression by the Gal-lectin of Entamoeba histolytica," The FASEB Journal, vol. 18, no. 1, pp. 155-157, 2004.
119. D. Vats, R. A. Vishwakarma, S. Bhattacharya, and A. Bhattacharya, "Reduction of cell surface glycosylphos-phatidylinositol conjugates in Entamoeba histolytica by antisense blocking of E. histolytica GlcNAc-phosphatidylinositol deacetylase expression: effect on cell proliferation, endocyto-sis, and adhesion to target cells," Infection and Immunity, vol. 73, no. 12, pp. 8381-8392, 2005. (Pubitemid 41740329)
120. Z. Zhang, M. Duchêne, and S. L. Stanley Jr., "A monoclonal antibody to the amebic lipophosphoglycan-proteophosphoglycan antigens can prevent disease in human intestinal xenografts infected with Entamoeba histolytica," Infection and Immunity, vol. 70, no. 10, pp. 5873-5876, 2002.
121. S. Moody, S. Becker, Y. Nuchamowitz, and D. Mirelman, "Virulent and avirulent Entamoeba histolytica and E. dispar differ in their cell surface phosphorylated glycolipids," Para-sitology, vol. 114, part 2, pp. 95-104, 1997. (Pubitemid 27095214)
122. L. Van Kaer and S. Joyce, "Innate immunity: NKT cells in the spotlight," Current Biology, vol. 15, no. 11, pp. R429-R431, 2005. (Pubitemid 40772144)
123. D. Zhou, J. Mattner, C. Cantu III, et al., "Lysosomal glycosphingolipid recognition by NKT cells," Science, vol. 306, no. 5702, pp. 1786-1789, 2004. (Pubitemid 39601398)
124. J. Mattner, K. L. DeBord, N. Ismail, et al., "Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections," Nature, vol. 434, no. 7032, pp. 525-529, 2005. (Pubitemid 40477062)
125. E. Acosta-Ramírez, R. Pérez-Flores, N. Majeau, et al., "Translating innate response into long-lasting antibody response by the intrinsic antigen-adjuvant properties of papaya mosaic virus," Immunology, vol. 124, no. 2, pp. 186-197, 2008. (Pubitemid 351692899)
126. L. Cervantes-Barragán, C. Gil-Cruz, R. Pastelin-Palacios, et al., "TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens," European Journal of Immunology, vol. 39, no. 1, pp. 126-135, 2009.
127. I. Secundino, C. López-Macías, L. Cervantes- Barragán, et al., "Salmonella porins induce a sustained, lifelong specific bactericidal antibody memory response," Immunology, vol. 117, no. 1, pp. 59-70, 2006.
128. + T cell response," Immunity, vol. 25, no. 4, pp. 655-664, 2006. (Pubitemid 44529033)
129. Q. Wang, R. M. McLoughlin, B. A. Cobb, et al., "A bacterial carbohydrate links innate and adaptive responses through To ll- li k e r e c e p t o r 2 ," Journal of Experimental Medicine, vol. 203, no. 13, pp. 2853-2863, 2006. (Pubitemid 46026163)
130. T. Querec, S. Bennouna, S. Alkan, et al., "Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity," Journal of Experimental Medicine, vol. 203, no. 2, pp. 413-424, 2006. (Pubitemid 43290850)
131. M. F. Delgado, S. Coviello, A. C. Monsalvo, et al., "Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease," Nature Medicine, vol. 15, no. 1, pp. 34-41, 2009.
132. P. Marrack, A. S. McKee, and M. W. Munks, "Towards an understanding of the adjuvant action of aluminium," Nature Reviews Immunology, vol. 9, no. 4, pp. 287-293, 2009.
133. N. W. Palm and R. Medzhitov, "Immunostimulatory activity of haptenated proteins," Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 12, pp. 4782-4787, 2009.